Information only — not investment advice; no trading here. Every number shows when it was observed and where it came from; stale sources are labelled as stale.

ESMC ESCALON MEDICAL CORP

equity · exchange OTC · CIK 0000862668 · trades in USD

AI brief AI-written, not reviewed by a person

Latest available figures show Cash and equivalents of 3,065,468 USD as of 2026-06-30, with a year-ago comparable of 3,342,537 USD on 2025-03-31, and 337,434 USD at 2025-12-31; stockholders’ equity rose to 5,927,733 USD by 2026-06-30 from 4,146,368 USD on 2026-03-31 and 1,772,932 USD on 2025-12-31. Net income for the 12 months ended 2026-06-30 is 4,012,626 USD, up from 105,525 USD for the year ended 2025-06-30; quarterly results show mixed turns, including a large positive quarter of 2,373,436 USD net income for the quarter ended 2026-03-31, versus a negative quarter of -419,263 USD in 2026-03-31 operating income. Revenue for the 12 months ended 2026-06-30 is 12,736,145 USD, higher than 12,046,148 USD for the year ended 2025-06-30; total assets stand at 9,128,115 USD as of 2026-06-30 with liabilities of 3,200,382 USD, indicating an improving but still leveraged balance sheet.

Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).

Observations

Latest observation per metric. Values are exactly as the source stated them.
MetricValueObservedSourceRetrievedFreshness
Revenue (quarter) (3 months to 2026-03-31) 2,608,523 USD sec-companyfacts current
Revenue (year) (12 months to 2026-06-30) 12,736,145 USD sec-companyfacts current
Net income (quarter) (3 months to 2026-03-31) 2,373,436 USD sec-companyfacts current
Net income (year) (12 months to 2026-06-30) 4,012,626 USD sec-companyfacts current
Operating income (quarter) (3 months to 2026-03-31) -419,263 USD sec-companyfacts current
Operating income (year) (12 months to 2026-06-30) 45,235 USD sec-companyfacts current
Diluted EPS (quarter) (3 months to 2026-03-31) 0.16 USD/shares sec-companyfacts current
Diluted EPS (year) (12 months to 2026-06-30) 0.27 USD/shares sec-companyfacts current
Operating cash flow (quarter) (3 months to 2025-09-30) 85,008 USD sec-companyfacts current
Operating cash flow (year) (12 months to 2026-06-30) -402,604 USD sec-companyfacts current
Total assets (at 2026-06-30) 9,128,115 USD sec-companyfacts current
Total liabilities (at 2026-06-30) 3,200,382 USD sec-companyfacts current
Stockholders' equity (at 2026-06-30) 5,927,733 USD sec-companyfacts current
Cash and equivalents (at 2026-06-30) 3,065,468 USD sec-companyfacts current
Long-term debt (at 2018-03-31) 18,853 USD sec-companyfacts current
Shares outstanding (at 2026-09-25) 7,415,329 shares sec-companyfacts current

Context

No reviewed context has been published for ESMC. The observations and documents below are shown as their sources stated them.

Documents

Feeds of ESMC documents: RSS · Atom · JSON Feed

Source freshness

Sources behind this page. A source is stale when its last successful fetch is older than its window.
SourceFreshnessLast successful fetchStale afterSources reports
SEC EDGAR: company financial facts (XBRL) sec-companyfacts current 10080 min ok
SEC EDGAR: latest XBRL filings sec-xbrl-filings current 45 min healthy

Watch this instrument

Sign in to add ESMC to a private watchlist or to get an alert when a new document or observation arrives.

Machine-readable: ESMC.json (the same data with every timestamp and source).

Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.